Table 3. Cost per DALY averted: base case and sensitivity analysis.
| Life expectancy (LE)a and late-effect morbidity scenario | Discounting | ||
|---|---|---|---|
| 0% | 3% | 6% | |
| Base case (Normal LE, no utility adjustment for late-effect morbidity) | $537b | $1,128b | $1,920c |
| Normal LE + utility adjustment for late effect morbidity | $567b | $1,151b | $1,932c |
| 15% Reduction in LE + utility adjustment for late-effect morbidity | $678b | $1,243b | $1,986c |
| 30% Reduction in LE + utility adjustment for late-effect morbidity | $845b | $1,388b | $2,087c |
Decrements in life expectancy selected based on Yeh et al [25]
Very cost-effective
Cost-effective